Posted inUncategorized
Keytruda and Lung Cancer Survival Rate
Introduction Lung cancer remains the leading cause of cancer-related mortality globally. The introduction of immune checkpoint inhibitors—particularly Keytruda (pembrolizumab), a PD-1 monoclonal antibody—has significantly improved survival outcomes in advanced and…